Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Vilaseca

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Journal of Inherited Metabolic Disease|July 10, 1999
NTBC as palliative treatment in chronic tyrosinaemia type IJ Ros, M A Vilaseca, N Lambruschini, et al.
Molecular Genetics and Metabolism|June 5, 1999
Biochemical phenotype and its relationship with genotype in hyperphenylalaninemia heterozygotesJ Mallolas, M Milà, N Lambruschini, et al.
The American Journal of Clinical Nutrition|October 28, 1999
Decreased serum ubiquinone-10 concentrations in phenylketonuriaR Artuch, M A Vilaseca, J Moreno, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 20, 2004
Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet?R Gassió, J Campistol, M A Vilaseca, et al.
Molecular Genetics and Metabolism|February 4, 2010
Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterinR Gassió, M A Vilaseca, N Lambruschini, et al.
Revista De Neurologia|March 30, 2005
[Inborn errors of metabolism with neurological symptomathology in the neonatal period]J Campistol, I Málaga-Diéguez, A García-Cazorla, et al.
Revista De Neurologia|June 1, 2005
[Encephalopathy with methylmalonic aciduria and homocystinuria secondary to a deficient exogenous supply of vitamin B12]G Gutiérrez-Aguilar, P Abenia-Usón, A García-Cazorla, et al.
Journal of Inherited Metabolic Disease|January 14, 1998
Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiencyM A García-Pérez, C Climent, P Briones, et al.
Revista De Neurologia|October 25, 2006
[Orientation of mental retardation from neurometabolic diseases]A García-Cazorla, B Pérez-Dueñas, M Pineda, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 12, 2009
Assessment of the perimortem protocol in neonates for the diagnosis of inborn errors of metabolismI Marín-Valencia, M A Vilaseca, M Thió, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Journal of Inherited Metabolic Disease|July 10, 1999
NTBC as palliative treatment in chronic tyrosinaemia type IJ Ros, M A Vilaseca, N Lambruschini, et al.
Molecular Genetics and Metabolism|June 5, 1999
Biochemical phenotype and its relationship with genotype in hyperphenylalaninemia heterozygotesJ Mallolas, M Milà, N Lambruschini, et al.
The American Journal of Clinical Nutrition|October 28, 1999
Decreased serum ubiquinone-10 concentrations in phenylketonuriaR Artuch, M A Vilaseca, J Moreno, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 20, 2004
Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet?R Gassió, J Campistol, M A Vilaseca, et al.
Molecular Genetics and Metabolism|February 4, 2010
Cognitive functions in patients with phenylketonuria in long-term treatment with tetrahydrobiopterinR Gassió, M A Vilaseca, N Lambruschini, et al.
Revista De Neurologia|March 30, 2005
[Inborn errors of metabolism with neurological symptomathology in the neonatal period]J Campistol, I Málaga-Diéguez, A García-Cazorla, et al.
Revista De Neurologia|June 1, 2005
[Encephalopathy with methylmalonic aciduria and homocystinuria secondary to a deficient exogenous supply of vitamin B12]G Gutiérrez-Aguilar, P Abenia-Usón, A García-Cazorla, et al.
Journal of Inherited Metabolic Disease|January 14, 1998
Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiencyM A García-Pérez, C Climent, P Briones, et al.
Revista De Neurologia|October 25, 2006
[Orientation of mental retardation from neurometabolic diseases]A García-Cazorla, B Pérez-Dueñas, M Pineda, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 12, 2009
Assessment of the perimortem protocol in neonates for the diagnosis of inborn errors of metabolismI Marín-Valencia, M A Vilaseca, M Thió, et al.
Pageof 12